carbenoxolone sodium has been researched along with inositol 1,4,5-trisphosphate in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Bol, M; Bultynck, G; De Bock, M; Decrock, E; Dupont, G; Leybaert, L; Ponsaerts, R; Wang, N | 1 |
Buckley, C; McCarron, JG; Wilson, C; Zhang, X | 1 |
2 other study(ies) available for carbenoxolone sodium and inositol 1,4,5-trisphosphate
Article | Year |
---|---|
Connexin 43 hemichannels contribute to cytoplasmic Ca2+ oscillations by providing a bimodal Ca2+-dependent Ca2+ entry pathway.
Topics: Adenosine Triphosphate; Animals; Bradykinin; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Signaling; Carbenoxolone; Cell Line; Connexin 43; Connexins; Cytochromes c; Cytoplasm; Dogs; Fluoresceins; Gap Junction beta-1 Protein; Gene Knockdown Techniques; Humans; Inositol 1,4,5-Trisphosphate; Oligopeptides; Peptides; Rats; Recombinant Proteins; RNA Interference | 2012 |
Carbenoxolone and 18β-glycyrrhetinic acid inhibit inositol 1,4,5-trisphosphate-mediated endothelial cell calcium signalling and depolarise mitochondria.
Topics: Calcium; Calcium Signaling; Carbenoxolone; Endothelial Cells; Gap Junctions; Glycyrrhetinic Acid; Inositol 1,4,5-Trisphosphate; Mitochondria | 2021 |